NCT05811247Phase 3Completed

Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

Study sponsor: Apnimed

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-05-07Actual
Enrollment · participants660Actual
Source updated2026-11-03Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from Baseline in Apnea-Hypopnea Index (AHI) Description: AHI, Apnea-Hypopnea Index, is the number of apneas or hypopneas recorded via polysomnography during the study per hour of sleep. Apnea is defined as a cessation of airflow lasting at least 10 seconds, hypopnea as a decrease in airflow by at least 30% from baseline for at least 10 seconds occurring with a drop in oxygen saturation (SpO2) by at least 4%. Time frame: 6 months. After: Measure: Change From Baseline in Apnea-Hypopnea Index (AHI) Description: AHI, Apnea-Hypopnea Index, is the number of apneas or hypopneas recorded via polysomnography during the study per hour of sleep. Apnea is defined as a cessation of airflow lasting at least 10 seconds, hypopnea as a decrease in airflow by at least 30% from baseline for at least 10 seconds occurring with a drop in oxygen saturation (SpO2) by at least 4%. Time frame: 6 months.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview